A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy

Molecular Pharmaceutics

Volumn 11, Issue 10, 2014, Pages 3269-3278

  Zhu, Qian ^a   Jia, Lixin ^a   Gao, Zhongfei ^a   Wang, Chunming ^a,b   Jiang, Haoyang ^a   Zhang, Junfeng ^a   Dong, Lei ^a  

^a NANJING UNIVERSITY   (China)

^b China jack1987168 163com   (Macao)

Author keywords

albumin encapsulated nanoparticle; doxorubicin; tumor environment responsive

Indexed keywords

ALBUMIN; DEOXYRIBONUCLEASE; DOXORUBICIN; ENZYME INHIBITOR; GELATIN; HUMAN SERUM ALBUMIN; MATRIX METALLOPROTEINASE; NANOPARTICLE; ANTINEOPLASTIC AGENT; DRUG CARRIER; SERUM ALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CLOTTING; CANCER TISSUE; CARDIOTOXICITY; CONTROLLED STUDY; DNA DRUG COMPLEX; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RELEASE; DRUG RESPONSE; DRUG TISSUE LEVEL; FEMALE; IN VITRO STUDY; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; STATIC ELECTRICITY; SURFACE PROPERTY; TOXICITY TESTING; TUMOR MICROENVIRONMENT; TUMOR MODEL; ZETA POTENTIAL; ANIMAL; CHEMISTRY; HUMAN; PROCEDURES; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MICE; NANOPARTICLES; SERUM ALBUMIN;

EID: 84907962645     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp4007776     Document Type: Article

References (50)

1. Tewey, K. M.; Rowe, T. C.; Yang, L.; Halligan, B. D.; Liu, L. F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II Science 1984, 226 (4673) 466-468
2. Singal, P. K.; Iliskovic, N. Doxorubicin-induced cardiomyopathy N. Engl. J. Med. 1998, 339 (13) 900-905
3. Lefrak, E. A.; Pitha, J.; Rosenheim, S.; Gottlieb, J. A. A clinicopathologic analysis of adriamycin cardiotoxicity Cancer 1973, 32 (2) 302-314
4. Ganz, W. I.; Sridhar, K. S.; Forness, T. J. Detection of early anthracycline cardiotoxicity by monitoring the peak filling rate Am. J. Clin. Oncol. 1993, 16 (2) 109-112
5. Steinherz, L. J.; Steinherz, P. G.; Tan, C. T.; Heller, G.; Murphy, M. L. Cardiac toxicity 4 to 20 years after completing anthracycline therapy J. Am. Med. Assoc. 1991, 266 (12) 1672-1677
6. Forssen, E. A.; Tokes, Z. A. Improved therapeutic benefits of doxorubicin by entrapment in anionic liposomes Cancer Res. 1983, 43 (2) 546-550
7. Haag, R.; Kratz, F. Polymer therapeutics: concepts and applications Angew. Chem., Int. Ed. 2006, 45 (8) 1198-1215
8. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 46 (12 Pt 1) 6387-6392
9. Dong, L.; Xia, S.; Wu, K.; Huang, Z.; Chen, H.; Chen, J.; Zhang, J. A pH/enzyme-responsive tumor-specific delivery system for doxorubicin Biomaterials 2010, 31 (24) 6309-6316
10. Dong, L.; Xia, S.; Chen, H.; Chen, J.; Zhang, J. Anti-arthritis activity of cationic materials J. Cell. Mol. Med. 2010, 14 (7) 2015-2024
11. Eklund, A. On the determination of available lysine in casein and rapeseed protein concentrates using 2,4,6-trinitrobenzenesulphonic acid (TNBS) as a reagent for free epsilon amino group of lysine Anal. Biochem. 1976, 70 (2) 434-439
12. de Jong, J.; Guerand, W. S.; Schoofs, P. R.; Bast, A.; van der Vijgh, W. J. Simple and sensitive quantification of anthracyclines in mouse atrial tissue using high-performance liquid chromatography and fluorescence detection J. Chromatogr. 1991, 570 (1) 209-216
13. Wang, H. Y.; Chen, J. X.; Sun, Y. X.; Deng, J. Z.; Li, C.; Zhang, X. Z.; Zhuo, R. X. Construction of cell penetrating peptide vectors with N-terminal stearylated nuclear localization signal for targeted delivery of DNA into the cell nuclei J. Controlled Release 2011, 155 (1) 26-33
14. Bates, S. M.; Weitz, J. I. Coagulation assays Circulation 2005, 112 (4) 53-60
15. Olson, H. M.; Young, D. M.; Prieur, D. J.; LeRoy, A. F.; Reagan, R. L. Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits Am. J. Pathol. 1974, 77 (3) 439-454
16. Grossman, W. Diastolic dysfunction in congestive heart failure N. Engl. J. Med. 1991, 325 (22) 1557-1564
17. Kiyomiya, K.; Matsuo, S.; Kurebe, M. Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex Cancer Res. 2001, 61 (6) 2467-2471
18. Vrignaud, S.; Benoit, J. P.; Saulnier, P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles Biomaterials 2011, 32 (33) 8593-8604
19. Senior, J. H. Fate and behavior of liposomes in vivo: a review of controlling factors Crit. Rev. Ther. Drug 1987, 3 (2) 123-193
20. Nagae, I.; Koyanagi, Y.; Ito, S.; Tanabe, Y.; Unezaki, S. Liposome drug delivery system for murine neuroblastoma J. Pediatr. Surg. 1998, 33 (10) 1521-1525
21. Maruyama, K. PEG-liposome in DDS and clinical studies Jpn. J. Clin. Med. 1998, 56 (3) 632-637
22. Torchilin, V. P.; Shtilman, M. I.; Trubetskoy, V. S.; Whiteman, K.; Milstein, A. M. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo Biochim. Biophys. Acta 1994, 1195 (1) 181-184
23. Kono, K.; Nakai, R.; Morimoto, K.; Takagishi, T. Thermosensitive polymer-modified liposomes that release contents around physiological temperature Biochim. Biophys. Acta 1999, 1416 (1-2) 239-250
24. Metselaar, J. M.; Bruin, P.; de Boer, L. W.; de Vringer, T.; Snel, C.; Oussoren, C.; Wauben, M. H.; Crommelin, D. J.; Storm, G.; Hennink, W. E. A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity Bioconjugate Chem. 2003, 14 (6) 1156-1164
25. Leo, E.; Arletti, R.; Forni, F.; Cameroni, R. General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles Farmaco 1997, 52 (6-7) 385-388
26. Hovorka, O.; Etrych, T.; Subr, V.; Strohalm, J.; Ulbrich, K.; Rihova, B. HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition J. Drug Targeting 2006, 14 (6) 391-403
27. Ohnuma, T.; Holland, J. F.; Chen, J. H. Pharmacological and therapeutic efficacy of daunomycin:DNA complex in mice Cancer Res. 1975, 35 (7) 1767-1772
28. Trouet, A.; de Duve, C. Letter: DNA complexes of daunorubicin (NSC-8215) and adriamycin (NSC-123127) Cancer Chemother. Rep. 1975, 59 (2 Part 1) 260
29. Cornu, G.; Michaux, J. L.; Sokal, G.; Trouet, A. Daunorubicin-DNA: further clinical trials in acute non-lymphoblastic leukemia Eur. J. Cancer 1974, 10 (11) 695-700
30. Trouet, A.; Deprez-De Campeneere, D. Daunorubicin-DNA and doxorubicin-DNA. A review of experimental and clinical data Cancer Chemother. Pharmacol. 1979, 2 (1) 77-79
31. Dorr, R. T.; Shipp, N. G.; Lee, K. M. Comparison of cytotoxicity in heart cells and tumor cells exposed to DNA intercalating agents in vitro Anti-Cancer Drugs 1991, 2 (1) 27-33
32. Wagner, E. Strategies to improve DNA polyplexes for in vivo gene transfer: will artificial viruses be the answer? Pharm. Res. 2004, 21 (1) 8-14
33. Paleos, C. M.; Tziveleka, L. A.; Sideratou, Z.; Tsiourvas, D. Gene delivery using functional dendritic polymers Expert Opin. Drug Delivery 2009, 6 (1) 27-38
34. Eliyahu, H.; Barenholz, Y.; Domb, A. J. Polymers for DNA delivery Molecules 2005, 10 (1) 34-64
35. Stamenkovic, I. Matrix metalloproteinases in tumor invasion and metastasis Semin. Cancer Biol. 2000, 10 (6) 415-433
36. Kragh-Hansen, U. Molecular aspects of ligand binding to serum albumin Pharmacol. Rev. 1981, 33 (1) 17-53
37. Peng, Q.; Zhang, S.; Yang, Q.; Zhang, T.; Wei, X. Q.; Jiang, L.; Zhang, C. L.; Chen, Q. M.; Zhang, Z. R.; Lin, Y. F. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system Biomaterials 2013, 34 (33) 8521-8530
38. Harries, M.; Ellis, P.; Harper, P. Nanoparticle albumin-bound paclitaxel for metastatic breast cancer J. Clin. Oncol. 2005, 23 (31) 7768-7771
39. Green, M. R.; Manikhas, G. M.; Orlov, S.; Afanasyev, B.; Makhson, A. M.; Bhar, P.; Hawkins, M. J. Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer Ann. Oncol. 2006, 17 (8) 1263-1268
40. Mansour, A. M.; Drevs, J.; Esser, N.; Hamada, F. M.; Badary, O. A.; Unger, C.; Fichtner, I.; Kratz, F. A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2 Cancer Res. 2003, 63 (14) 4062-4066
41. Gabor, F.; Wollmann, K.; Theyer, G.; Haberl, I.; Hamilton, G. In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells Anticancer Res. 1994, 14 (5A) 1943-1950
42. Xu, R.; Fisher, M.; Juliano, R. L. Targeted albumin-based nanoparticles for delivery of amphipathic drugs Bioconjugate Chem. 2011, 22 (5) 870-878
43. Wu, Y.; Ihme, S.; Feuring-Buske, M.; Kuan, S. L.; Eisele, K.; Lamla, M.; Wang, Y.; Buske, C.; Weil, T. A core-shell albumin copolymer nanotransporter for high capacity loading and two-step release of doxorubicin with enhanced anti-leukemia activity Adv. Healthcare Mater. 2013, 2 (6) 884-894
44. Bae, S.; Ma, K.; Kim, T. H.; Lee, E. S.; Oh, K. T.; Park, E. S.; Lee, K. C.; Youn, Y. S. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types Biomaterials 2012, 33 (5) 1536-1546
45. Du, C.; Deng, D.; Shan, L.; Wan, S.; Cao, J.; Tian, J.; Achilefu, S.; Gu, Y. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery Biomaterials 2013, 34 (12) 3087-3097
46. Jung, S. H.; Kim, S. K.; Kim, E. H.; Cho, S. H.; Jeong, K. S.; Seong, H.; Shin, B. C. Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes Colloids Surf., B 2010, 76 (2) 434-440
47. Wu, Y.; Shih, E. K.; Ramanathan, A.; Vasudevan, S.; Weil, T. Nano-sized albumin-copolymer micelles for efficient doxorubicin delivery Biointerphases 2012, 7 (1-4) 5
48. Rhaese, S.; von Briesen, H.; Rubsamen-Waigmann, H.; Kreuter, J.; Langer, K. Human serum albumin-polyethylenimine nanoparticles for gene delivery J. Controlled Release 2003, 92 (1-2) 199-208
49. Babson, A. L.; Winnick, T. Protein transfer in tumor-bearing rats Cancer Res. 1954, 14 (8) 606-611
50. Peters, T. Serum albumin Adv. Protein Chem. 1985, 37, 161-245